DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LIDODERM

« Back to Dashboard

505(b)(2) Clinical Trials for Lidoderm

This table shows clinical trials for potential 505(b)(2) applications. See the next table for all clinical trials

Trial Type	Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
OTC	NCT02749123	Comparison of Prescription Lidocaine Patch to Over the Counter Lidocaine Patch and Placebo for Back Pain and Arthritis	Recruiting	J.A.R. Laboratories	N/A	2016-04-01	A comparison of transdermal patches for efficacy, side effects and quality of life for patients with back pain and arthritis. The three arms in the trial were; prescription strength lidocaine 5%, over the counter lidocaine 3.6%, menthol 1.25% and placebo.

All Clinical Trials for Lidoderm

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00266214	Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome	Terminated	Endo Pharmaceuticals	Phase 3	2005-11-01	The purpose of this study is to evaluate the analgesic efficacy and safety of the lidocaine patch 5% compared to placebo in patients with moderate to severe pain associated with carpal tunnel syndrome.
NCT00414453	Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis	Terminated	Endo Pharmaceuticals	Phase 4	2007-01-01	This study will determine whether treatment with an extended-release opioid or topical lidocaine is effective in relieving distal symmetric lower extremity burning pain associated with multiple sclerosis (MS). If treatment with topical lidocaine is efficacious, it will have important implications for understanding this chronic pain syndrome, which is widely assumed to be caused by central nervous system pathology.
NCT00414453	Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis	Terminated	University of Rochester	Phase 4	2007-01-01	This study will determine whether treatment with an extended-release opioid or topical lidocaine is effective in relieving distal symmetric lower extremity burning pain associated with multiple sclerosis (MS). If treatment with topical lidocaine is efficacious, it will have important implications for understanding this chronic pain syndrome, which is widely assumed to be caused by central nervous system pathology.

Clinical Trial Conditions for Lidoderm

Condition Name

Condition Name for Lidoderm
Intervention	Trials
Healthy	4
Postherpetic Neuralgia	3
Osteoarthritis of the Knee	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Lidoderm
Intervention	Trials
Back Pain	5
Neuralgia	4
Low Back Pain	4

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Lidoderm

Trials by Country

Trials by Country for Lidoderm
Location	Trials
United States	64

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Lidoderm
Location	Trials
Florida	7
Pennsylvania	6
Arizona	6
Alabama	5
New York	4

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Lidoderm

Clinical Trial Phase

Clinical Trial Phase for Lidoderm
Clinical Trial Phase	Trials
Phase 4	10
Phase 3	1
Phase 2	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Lidoderm
Clinical Trial Phase	Trials
Completed	13
Terminated	3
Recruiting	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Lidoderm

Sponsor Name

Sponsor Name for Lidoderm
Sponsor	Trials
Endo Pharmaceuticals	11
Scilex Pharmaceuticals, Inc.	2
Nuvo Research Inc.	1

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Lidoderm
Sponsor	Trials
Industry	16
Other	8

Export unavailable in trial.
Subscribe for complete access.